Scholarlink

Objectives <p>This study aims to investigate the impact of the pro-osteoblastogenic ERK-activated ribosomal S6 kinase (<i>Rsk2)</i> on Tumor necrosis factor (TNF)α-induced bone loss in the craniofacial system, focusing on its role in rheumatoid arthritis (RA). The objective is to understand whether <i>Rsk2</i>, previously shown to have protective effects in long bones against TNFα-induced bone resorption, exhibits similar effects in the craniofacial region.</p> Materials <p>, and Methods.</p> <p>The study compares mice with TNFα overexpression, <i>Rsk2</i> knockout mice, and a combination of TNFα, and <i>Rsk2</i> knockout mice using detailed micro-computed tomography coupled with landmark based morphometric analysis, and classical histology. The overall skull morphology, mandible shape, and the temporomandibular joint were examined. Additionally, histological sections were utilized to examine the synovial membrane.</p> Results <p>Combining TNFα, and <i>Rsk2</i> deficiency does not further alter overall skull shape compared to TNFα alone. TNFα overexpression shortens the mandibular ramus, exacerbated by <i>Rsk2</i> absence. Micro-computed tomography (µCT) reveals significant temporomandibular joint damage from TNFα, independent of <i>Rsk2</i>. However, histological sections show increased synovial membrane thickness with TNFα, heightened in the absence of <i>Rsk2</i>.</p> Conclusions <p><i>Rsk2</i> mitigates TNFα-induced effects on mandibular ramus length in the craniofacial system but has limited impact on the temporomandibular joint, except for synovial membrane thickness. Overall, <i>Rsk2</i> demonstrates a weaker preventive effect on TNFα-induced craniofacial bone loss compared to its established role in the appendicular skeleton.</p> Clinical Relevance <p>This study highlights regional differences in <i>Rsk2's</i> protective mechanisms, emphasizing the need for further exploration of the underlying mechanisms for these disparities. Understanding these regional differences can be crucial for the development of targeted therapeutic interventions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The effect of Rsk2 on TNFα-mediated bone loss in the TMJ and craniofacial skeleton

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月26日

查看全文
  • Gina Marie Georgi,
  • Frédéric Bachmann,
  • Julia Luther,
  • Anja Derer,
  • Patrick Heimel,
  • Stefan Tangl,
  • Bärbel Kahl-Nieke,
  • Aaron LeBlanc,
  • Jill Helms,
  • Georg Schett,
  • Christian Hirsch,
  • Reinhard Gruber,
  • Michael Amling,
  • Thorsten Schinke,
  • Till Koehne,
  • Julian Petersen

摘要

Objectives

This study aims to investigate the impact of the pro-osteoblastogenic ERK-activated ribosomal S6 kinase (Rsk2) on Tumor necrosis factor (TNF)α-induced bone loss in the craniofacial system, focusing on its role in rheumatoid arthritis (RA). The objective is to understand whether Rsk2, previously shown to have protective effects in long bones against TNFα-induced bone resorption, exhibits similar effects in the craniofacial region.

Materials

, and Methods.

The study compares mice with TNFα overexpression, Rsk2 knockout mice, and a combination of TNFα, and Rsk2 knockout mice using detailed micro-computed tomography coupled with landmark based morphometric analysis, and classical histology. The overall skull morphology, mandible shape, and the temporomandibular joint were examined. Additionally, histological sections were utilized to examine the synovial membrane.

Results

Combining TNFα, and Rsk2 deficiency does not further alter overall skull shape compared to TNFα alone. TNFα overexpression shortens the mandibular ramus, exacerbated by Rsk2 absence. Micro-computed tomography (µCT) reveals significant temporomandibular joint damage from TNFα, independent of Rsk2. However, histological sections show increased synovial membrane thickness with TNFα, heightened in the absence of Rsk2.

Conclusions

Rsk2 mitigates TNFα-induced effects on mandibular ramus length in the craniofacial system but has limited impact on the temporomandibular joint, except for synovial membrane thickness. Overall, Rsk2 demonstrates a weaker preventive effect on TNFα-induced craniofacial bone loss compared to its established role in the appendicular skeleton.

Clinical Relevance

This study highlights regional differences in Rsk2's protective mechanisms, emphasizing the need for further exploration of the underlying mechanisms for these disparities. Understanding these regional differences can be crucial for the development of targeted therapeutic interventions.